Optical coherence tomography angiography (OCTA) is a new imaging technology that allows the non-invasive and rapid reconstruction of the three-dimensional structure of the retinal and choroidal vascularization.Importantly, blood flow signals within the vessels can be derived from consecutive scans of the selected areas.
OCTA can show vascular structure consistent with conventional angiography, although it cannot yet calculate the filling time and evaluate the function of the blood-retinal barrier. OCTA can reveal deep capillary networks better than ever and detect choroidal neovascularization much earlier, providing additional information of
the underlying pathology. Thus, it is now being widely used in diabetic retinopathy, macular telangiectasia,age-related macular degeneration, central serous chorioretinopathy, retinal vein occlusion, and other fundus vascular diseases. Currently, this new technology still has some limitations such as movement artifacts and projection of superficial retinal vessels at the level of the retinal pigment epithelium. However with upgrades in the equipment and software, the current techniques will be improved, providing images more clearly. As a result, we will develop a more thorough understanding of the diseases.
俞素勤,李欣馨,许迅. OCT血流成像技术的现在与未来[J]. 中华眼视光学与视觉科学杂志, 2017, 19(10): 577-585.
Suqin Yu,Xinxin Li,Xun Xu. The Present and Future of OCT Angiography. Chinese Journal of Optometry Ophthalmology and Visual science, 2017, 19(10): 577-585. DOI: 10.3760/cma.j.issn.1674-845X.2017.10.001
Jia Y, Bailey ST, Hwang TS, et al. Quantitative optical coherence tomography angiography of vascularabnormalities in the living human eye. Proc Natl Acad Sci USA, 2015, 112(18):
E2395-2402. DOI: 10.1073/pnas.1500185112.
[2]
Chalam KV, Sambhav K. Optical coherence tomography angiography in retinal diseases. J Ophthalmic Vis Res, 2016,11(1): 84-92. DOI: 10.4103/2008-322X.180709.
[3]
Pierro L, BattagliaParodi M, Rabiolo A, et al. Optical coherence tomography angiography of miscellaneous retinal disease. Dev Ophthalmol, 2016, 56: 174-180. DOI:10.1159/000442810.
[4]
de Carlo TE, Romano A, Waheed NK, et al. A review of optical coherence tomography angiography (OCTA). Int J Retina Vitreous, 2015, 1: 5. DOI: 10.1186/s40942-015-0005-8.
[1]
Jia Y, Bailey ST, Hwang TS, et al. Quantitative optical coherence tomography angiography of vascularabnormalities in the living human eye. Proc Natl Acad Sci USA, 2015, 112(18):
E2395-2402. DOI: 10.1073/pnas.1500185112.
[2]
Chalam KV, Sambhav K. Optical coherence tomography angiography in retinal diseases. J Ophthalmic Vis Res, 2016,11(1): 84-92. DOI: 10.4103/2008-322X.180709.
[3]
Pierro L, BattagliaParodi M, Rabiolo A, et al. Optical coherence tomography angiography of miscellaneous retinal disease. Dev Ophthalmol, 2016, 56: 174-180. DOI:10.1159/000442810.
[4]
de Carlo TE, Romano A, Waheed NK, et al. A review of optical coherence tomography angiography (OCTA). Int J Retina Vitreous, 2015, 1: 5. DOI: 10.1186/s40942-015-0005-8.
[5]
Zhang M, Wang J, Pechauer AD, et al. Advanced image processing for optical coherence tomographic angiography of macular diseases. Biomed Opt Express, 2015, 6(12): 4661-
46
75. DOI: 10.1364/BOE.6.004661.
[6]
Jia Y, Tan O, Tokayer J, et al. Split-spectrum amplitude-decorrelation angiography with optical coherence tomography. Opt Express,2012, 20(4): 4710-4725. DOI: 10.1364/OE.20. 004710.
[7]
Puliafito CA. OCT angiography: the next era of OCT technology emerges. Ophthalmic Surg Lasers Imaging Retina, 2014, 45(5):360. DOI: 10.3928/23258160-20140925-01.
[8]
Coscas G, Lupidi M, Coscas F. Heidelberg spectralis optical coherence tomography angiography: technical aspects. Dev Ophthalmol, 2016, 56: 1-5. DOI: 10.1159/000442768.
[9]
Huang D, Jia Y, Gao SS, et al. Optical coherence tomography angiography using the optovue device. Dev Ophthalmol, 2016,56: 6-12. DOI: 10.1159/000442770.
[10]
Stanga PE, Tsamis E, Papayannis A, et al. Swept-source optical coherence tomography angioTM (Topcon Corp, Japan):technology review. Dev Ophthalmol, 2016, 56: 13-17. DOI:10.1159/0004 42771.
[11]
Wang RK, An L, Francis P, et al. Depth-resolved imaging of capillary networks in retina and choroid using ultrahigh sensitive optical microangiography. Opt Lett, 2010, 35(9): 1467-1469.DOI: 10.1364/OL.35.001467.
[12]
Zhang A, Zhang Q, Chen CL, et al. Methods and algorithms for optical coherence tomography-based angiography: a review and comparison. J Biomed Opt, 2015, 20(10): 100901. DOI:10.1117/1.JBO.20.10.100901.
[13]
Wang RK. Optical microangiography: a label free 3D imaging technology to visualize and quantify blood circulations within tissue beds in vivo. IEEE J Sel Top Quantum Electron, 2010,16(3): 545-554. DOI: 10.1109/JSTQE.2009.2033609.
[14]
Ishibazawa A, Nagaoka T, Takahashi A, et al. Optical coherence tomography angiography in diabetic retinopathy: a prospective pilot study. Am J Ophthalmol, 2015, 160(1): 35-44. DOI: 10.1016/j.ajo.2015.04.021.
[15]
Bradley PD, Sim DA, Keane PA, et al. The evaluation of diabetic macular ischemia using optical coherence tomography angiography. Invest Ophthalmol Vis Sci, 2016, 57(2): 626-631.DOI: 10.1167/iovs.15-18034.
[16]
Ishibazawa A, Nagaoka T, Yokota H, et al. Characteristics of retinal neovascularization in proliferative diabetic retinopathy imaged by optical coherence tomography angiography. Invest Ophthalmol Vis Sci, 2016, 57(14): 6247-6255. DOI: 10.1167/iovs.16-20210.
[17]
Lee J, Rosen R. Optical coherence tomography angiography in diabetes. Curr Diab Rep, 2016, 16(12): 123. DOI: 10.1007/s11892-016-0811-x.
[5]
Zhang M, Wang J, Pechauer AD, et al. Advanced image processing for optical coherence tomographic angiography of macular diseases. Biomed Opt Express, 2015, 6(12): 4661-
46
75. DOI: 10.1364/BOE.6.004661.
[6]
Jia Y, Tan O, Tokayer J, et al. Split-spectrum amplitude-decorrelation angiography with optical coherence tomography. Opt Express,2012, 20(4): 4710-4725. DOI: 10.1364/OE.20. 004710.
[7]
Puliafito CA. OCT angiography: the next era of OCT technology emerges. Ophthalmic Surg Lasers Imaging Retina, 2014, 45(5):360. DOI: 10.3928/23258160-20140925-01.
[8]
Coscas G, Lupidi M, Coscas F. Heidelberg spectralis optical coherence tomography angiography: technical aspects. Dev Ophthalmol, 2016, 56: 1-5. DOI: 10.1159/000442768.
[9]
Huang D, Jia Y, Gao SS, et al. Optical coherence tomography angiography using the optovue device. Dev Ophthalmol, 2016,56: 6-12. DOI: 10.1159/000442770.
[10]
Stanga PE, Tsamis E, Papayannis A, et al. Swept-source optical coherence tomography angioTM (Topcon Corp, Japan):technology review. Dev Ophthalmol, 2016, 56: 13-17. DOI:10.1159/0004 42771.
[11]
Wang RK, An L, Francis P, et al. Depth-resolved imaging of capillary networks in retina and choroid using ultrahigh sensitive optical microangiography. Opt Lett, 2010, 35(9): 1467-1469.DOI: 10.1364/OL.35.001467.
[12]
Zhang A, Zhang Q, Chen CL, et al. Methods and algorithms for optical coherence tomography-based angiography: a review and comparison. J Biomed Opt, 2015, 20(10): 100901. DOI:10.1117/1.JBO.20.10.100901.
[13]
Wang RK. Optical microangiography: a label free 3D imaging technology to visualize and quantify blood circulations within tissue beds in vivo. IEEE J Sel Top Quantum Electron, 2010,16(3): 545-554. DOI: 10.1109/JSTQE.2009.2033609.
[14]
Ishibazawa A, Nagaoka T, Takahashi A, et al. Optical coherence tomography angiography in diabetic retinopathy: a prospective pilot study. Am J Ophthalmol, 2015, 160(1): 35-44. DOI: 10.1016/j.ajo.2015.04.021.
[15]
Bradley PD, Sim DA, Keane PA, et al. The evaluation of diabetic macular ischemia using optical coherence tomography angiography. Invest Ophthalmol Vis Sci, 2016, 57(2): 626-631.DOI: 10.1167/iovs.15-18034.
[16]
Ishibazawa A, Nagaoka T, Yokota H, et al. Characteristics of retinal neovascularization in proliferative diabetic retinopathy imaged by optical coherence tomography angiography. Invest Ophthalmol Vis Sci, 2016, 57(14): 6247-6255. DOI: 10.1167/iovs.16-20210.
[17]
Lee J, Rosen R. Optical coherence tomography angiography in diabetes. Curr Diab Rep, 2016, 16(12): 123. DOI: 10.1007/s11892-016-0811-x.
[18]
de Carlo TE, Moult E, Choi W, et al. Non-neovascular age- related macular degeneration//Clinical OCT angiography atlas, 1st ed.Lumbroso B, Huang D, Chen CJ, et al, eds. New Delhi, India:Jaypee Brothers Medical Publishers, 2015: 75-88.
[19]
Toto L, Borrelli E, Di Antonio L, et al. Retinal vascular plexuses' changes in dry age-related macular degeneration, evaluated by means of optical coherence tomography angiography. Retina,2016, 36(8): 1566-1572. DOI: 10.1097/IAE.0000000000000962.
[20]
Choi W, Moult E, Waheed NK, et al. Ultrahigh-speed, swept- source optical coherence tomography angiography in non-exudative age-related macular degeneration with geographic atrophy.Ophthalmology, 2015, 122(12): 2532-2544. DOI: 10.1016/j.ophtha.2015.08.029.
[21]
Moult E, Choi W, Waheed NK, et al. Ultrahigh-speed swept-source OCT angiography in exudative AMD. Ophthalmic Surg Lasers Imaging Retina, 2014, 45(6): 496-505. DOI: 10.3928/23258160-20141118-03.
[22]
Jia Y, Bailey ST, Wilson DJ, et al. Quantitative optical coherence tomography angiography of choroidal neovascularization in age-related macular degeneration. Ophthalmology, 2014, 121(7):1435-1444. DOI: 10.1016/j.ophtha.2014.01.034.
[23]
McClintic SM, Kim DY, Fingler J, et al. Detection of pigment epithelial detachment vascularization in age-related macular degeneration using phase-variance OCT angiography. Clin Ophthalmol, 2015, 9: 1299-1305. DOI: 10.2147/OPTH.S83701.
[18]
de Carlo TE, Moult E, Choi W, et al. Non-neovascular age- related macular degeneration//Clinical OCT angiography atlas, 1st ed.Lumbroso B, Huang D, Chen CJ, et al, eds. New Delhi, India:Jaypee Brothers Medical Publishers, 2015: 75-88.
[19]
Toto L, Borrelli E, Di Antonio L, et al. Retinal vascular plexuses' changes in dry age-related macular degeneration, evaluated by means of optical coherence tomography angiography. Retina,2016, 36(8): 1566-1572. DOI: 10.1097/IAE.0000000000000962.
[20]
Choi W, Moult E, Waheed NK, et al. Ultrahigh-speed, swept- source optical coherence tomography angiography in non-exudative age-related macular degeneration with geographic atrophy.Ophthalmology, 2015, 122(12): 2532-2544. DOI: 10.1016/j.ophtha.2015.08.029.
[21]
Moult E, Choi W, Waheed NK, et al. Ultrahigh-speed swept-source OCT angiography in exudative AMD. Ophthalmic Surg Lasers Imaging Retina, 2014, 45(6): 496-505. DOI: 10.3928/23258160-20141118-03.
[22]
Jia Y, Bailey ST, Wilson DJ, et al. Quantitative optical coherence tomography angiography of choroidal neovascularization in age-related macular degeneration. Ophthalmology, 2014, 121(7):1435-1444. DOI: 10.1016/j.ophtha.2014.01.034.
[23]
McClintic SM, Kim DY, Fingler J, et al. Detection of pigment epithelial detachment vascularization in age-related macular degeneration using phase-variance OCT angiography. Clin Ophthalmol, 2015, 9: 1299-1305. DOI: 10.2147/OPTH.S83701.
[24]
Kuehlewein L, Bansal M, Lenis TL, et al. Optical coherence tomography angiography of type 1 neovascularization in age-related macular degeneration. Am J Ophthalmol, 2015,
16
0(4): 739-748.e2. DOI: 10.1016/j.ajo.2015.06.030.
[25]
Kuehlewein L, Sadda SR, Sarraf D. OCT angiography and sequential quantitative analysis of type 2 neovascularization after ranibizumab therapy. Eye (Lond), 2015, 29(7): 932-935.DOI: 10.1038/eye.2015.80.
[26]
Querques G, Miere A, Souied EH. Optical coherence tomography angiography features of type 3 neovascularization in age-related macular degeneration. Dev Ophthalmol, 2016, 56: 57-61. DOI:10.1159/000442779.
[27]
Coscas G, Lupidi M, Coscas F, et al. Optical coherence tomography angiography during follow-up: qualitative and quantitative analysis of mixed type I and II choroidal neovascularization after vascular endothelial growth factor trap therapy. Ophthalmic Res, 2015, 54(2): 57-63. DOI: 10.1159/000433547.
[28]
Marques JP, Costa JF, Marques M, et al. Sequential morphological changes in the CNV net after intravitreal anti-VEGF evaluated with OCT angiography. Ophthalmic Res, 2016, 55(3): 145-151.DOI: 10.1159/000442671.
[29]
Lumbroso B, Rispoli M, Savastano MC, et al. Optical coherence tomography angiography study of choroidal neovascularization early response after treatment. Dev Ophthalmol, 2016, 56: 77-85. DOI: 10.1159/000442782.
[24]
Kuehlewein L, Bansal M, Lenis TL, et al. Optical coherence tomography angiography of type 1 neovascularization in age-related macular degeneration. Am J Ophthalmol, 2015,
16
0(4): 739-748.e2. DOI: 10.1016/j.ajo.2015.06.030.
[25]
Kuehlewein L, Sadda SR, Sarraf D. OCT angiography and sequential quantitative analysis of type 2 neovascularization after ranibizumab therapy. Eye (Lond), 2015, 29(7): 932-935.DOI: 10.1038/eye.2015.80.
[26]
Querques G, Miere A, Souied EH. Optical coherence tomography angiography features of type 3 neovascularization in age-related macular degeneration. Dev Ophthalmol, 2016, 56: 57-61. DOI:10.1159/000442779.
[27]
Coscas G, Lupidi M, Coscas F, et al. Optical coherence tomography angiography during follow-up: qualitative and quantitative analysis of mixed type I and II choroidal neovascularization after vascular endothelial growth factor trap therapy. Ophthalmic Res, 2015, 54(2): 57-63. DOI: 10.1159/000433547.
[28]
Marques JP, Costa JF, Marques M, et al. Sequential morphological changes in the CNV net after intravitreal anti-VEGF evaluated with OCT angiography. Ophthalmic Res, 2016, 55(3): 145-151.DOI: 10.1159/000442671.
[29]
Lumbroso B, Rispoli M, Savastano MC, et al. Optical coherence tomography angiography study of choroidal neovascularization early response after treatment. Dev Ophthalmol, 2016, 56: 77-85. DOI: 10.1159/000442782.
[30]
Nehemy MB, Brocchi DN, Veloso CE. Optical coherence tomography angiography imaging of quiescent choroidal neovascularization in age-related macular degeneration.
Charbel Issa P, vander Veen RL, Stijfs A, et al. Quantification of reduced macular pigment optical density in the central retina in macular telangiectasia type 2. Exp Eye Res, 2009, 89(1): 25-31.DOI: 10.1016/j.exer.2009.02.006.
[34]
Cohen SM, Cohen ML, El-Jabali F, et al. Optical coherence tomography findings in nonproliferative group 2a idiopathicjuxtafoveal retinal telangiectasis. Retina, 2007, 27(1):59-66. DOI: 10.1097/01.iae.0000256663.94734.e1.
[35]
Powner MB, Gillies MC, Tretiach M, et al. Perifoveal Muller cell depletion in a case of macular telangiectasia type 2.Ophthalmology, 2010, 117(12): 2407-2416. DOI:10.1016/j.ophtha.2010.04.001.
[36]
Powner MB, Gillies MC, Zhu M, et al. Loss of Müller's cells and photoreceptors in macular telangiectasia type 2. Ophthalmology,2013, 120: 2344-2352. DOI:10.1016/j.ophtha.2013.04.013.
[37]
Spaide RF, Klancnik JM Jr, Cooney MJ. Retinal vascular layers in macular telangiectasia type 2 imaged by optical coherence tomographic angiography. JAMA Ophthalmol, 2015, 133(1):66-73. DOI: 10.1001/jamaophthalmol.2014.3950.
Charbel Issa P, vander Veen RL, Stijfs A, et al. Quantification of reduced macular pigment optical density in the central retina in macular telangiectasia type 2. Exp Eye Res, 2009, 89(1): 25-31.DOI: 10.1016/j.exer.2009.02.006.
[34]
Cohen SM, Cohen ML, El-Jabali F, et al. Optical coherence tomography findings in nonproliferative group 2a idiopathicjuxtafoveal retinal telangiectasis. Retina, 2007, 27(1):59-66. DOI: 10.1097/01.iae.0000256663.94734.e1.
[35]
Powner MB, Gillies MC, Tretiach M, et al. Perifoveal Muller cell depletion in a case of macular telangiectasia type 2.Ophthalmology, 2010, 117(12): 2407-2416. DOI:10.1016/j.ophtha.2010.04.001.
[36]
Powner MB, Gillies MC, Zhu M, et al. Loss of Müller's cells and photoreceptors in macular telangiectasia type 2. Ophthalmology,2013, 120: 2344-2352. DOI:10.1016/j.ophtha.2013.04.013.
[37]
Spaide RF, Klancnik JM Jr, Cooney MJ. Retinal vascular layers in macular telangiectasia type 2 imaged by optical coherence tomographic angiography. JAMA Ophthalmol, 2015, 133(1):66-73. DOI: 10.1001/jamaophthalmol.2014.3950.
[38]
Spaide RF, Klancnik JM Jr, Cooney MJ, et al. Volume-rendering optical coherence tomography angiography of macular telangiectasia type 2. Ophthalmology, 2015, 122(11): 2261-
22
69. DOI: 10.1016/j.ophtha.2015.07.025.
[39]
Roisman L, Rosenfeld PJ. Optical coherence tomography angiography of macular telangiectasia type 2. Dev Ophthalmol,2016, 56: 146-158. DOI: 10.1159/000442807.
[40]
Quaranta-El Maftouhi M, El Maftouhi A, Eandi CM. Chronic central serous chorioretinopathy imaged by optical coherence tomographic angiography. Am J Ophthalmol, 2015, 160(3): 581-587. DOI: 10.1016/j.ajo.2015.06.016.
[41]
McClintic SM, Jia Y, Huang D, et al. Optical coherence tomographic angiography of choroidal neovascularization associated with central serous chorioretinopathy. JAMA Ophthalmol, 2015,133(10): 1212-1214. DOI: 10.1001/jamaophthalmol.2015.2126.
[42]
Weng S, Mao L, Yu S, et al. Detection of choroidal neovascularization in central serous chorioretinopathy using optical coherence tomographic angiography. Ophthalmologica, 2016, 236(2): 114-121. DOI: 10.1159/000448630.
[43]
Querques G, Corvi F, Querques L, et al. Optical coherence tomography angiography of choroidal neovascularization secondary to pathologic myopia. Dev Ophthalmol, 2016, 56:101-106. DOI: 10.1159/000442800.
Spaide RF, Klancnik JM Jr, Cooney MJ, et al. Volume-rendering optical coherence tomography angiography of macular telangiectasia type 2. Ophthalmology, 2015, 122(11): 2261-
22
69. DOI: 10.1016/j.ophtha.2015.07.025.
[39]
Roisman L, Rosenfeld PJ. Optical coherence tomography angiography of macular telangiectasia type 2. Dev Ophthalmol,2016, 56: 146-158. DOI: 10.1159/000442807.
[40]
Quaranta-El Maftouhi M, El Maftouhi A, Eandi CM. Chronic central serous chorioretinopathy imaged by optical coherence tomographic angiography. Am J Ophthalmol, 2015, 160(3): 581-587. DOI: 10.1016/j.ajo.2015.06.016.
[41]
McClintic SM, Jia Y, Huang D, et al. Optical coherence tomographic angiography of choroidal neovascularization associated with central serous chorioretinopathy. JAMA Ophthalmol, 2015,133(10): 1212-1214. DOI: 10.1001/jamaophthalmol.2015.2126.
[42]
Weng S, Mao L, Yu S, et al. Detection of choroidal neovascularization in central serous chorioretinopathy using optical coherence tomographic angiography. Ophthalmologica, 2016, 236(2): 114-121. DOI: 10.1159/000448630.
[43]
Querques G, Corvi F, Querques L, et al. Optical coherence tomography angiography of choroidal neovascularization secondary to pathologic myopia. Dev Ophthalmol, 2016, 56:101-106. DOI: 10.1159/000442800.
Cheng L, Chen X, Weng S, et al. Spectral-domain optical coherence tomography angiography findings in multifocal choroiditis with active lesions. Am J Ophthalmol, 2016, 169:145-161. DOI: 10.1016/j.ajo.2016.06.029.
[48]
Cerquaglia A, Lupidi M, Fiore T, et al. Deep inside multifocal choroiditis: an optical coherence tomography angiography approach. Int Ophthalmol, 2016 Sep 2. [Epub ahead of print]DOI: 10.1007/s10792-016-0300-x.
[49]
Coscas F, Glacet-Bernard A, Miere A, et al. Optical coherence tomography angiography in retinal vein occlusion: evaluation of superficial and deep capillary plexa. Am J Ophthalmol, 2016,161: 160-171. e1-2. DOI: 10.1016/j.ajo.2015.10.008.
[50]
Jia Y, Morrison JC, Tokayer J, et al. Quantitative OCT angiography of optic nerve head blood flow. Biomed Opt Express, 2012,3(12): 3127-3137. DOI: 10.1364/BOE.3.003127.
[51]
Jia Y, Wei E, Wang X, et al. Optical coherence tomography angiography of optic disc perfusion in glaucoma. Ophthalmology, 2014,121(7): 1322-1332. DOI: 10.1016/j.ophtha.2014.01.021.
[52]
Wang X, Jiang C, Ko T, et al. Correlation between optic disc perfusion and glaucomatous severity in patients with open-angle glaucoma: an optical coherence tomography angiography study.Graefes Arch Clin Exp Ophthalmol, 2015, 253(9): 1557-1564.DOI: 10.1007/s00417-015-3095-y.
[53]
Liu L, Jia Y, Takusagawa HL, et al. Optical coherence tomography angiography of the peripapillary retina in glaucoma.JAMA Ophthalmol, 2015, 133(9): 1045-1052. DOI: 10.1001/jamaophthalmol.2015.2225.
[45]
Kotsolis AI, Killian FA, Ladas ID, et al. Fluorescein angiography and optical coherence tomography concordance for choroidalneovascularisation in multifocal choroidtis. Br J
Cheng L, Chen X, Weng S, et al. Spectral-domain optical coherence tomography angiography findings in multifocal choroiditis with active lesions. Am J Ophthalmol, 2016, 169:145-161. DOI: 10.1016/j.ajo.2016.06.029.
[48]
Cerquaglia A, Lupidi M, Fiore T, et al. Deep inside multifocal choroiditis: an optical coherence tomography angiography approach. Int Ophthalmol, 2016 Sep 2. [Epub ahead of print]DOI: 10.1007/s10792-016-0300-x.
[49]
Coscas F, Glacet-Bernard A, Miere A, et al. Optical coherence tomography angiography in retinal vein occlusion: evaluation of superficial and deep capillary plexa. Am J Ophthalmol, 2016,161: 160-171. e1-2. DOI: 10.1016/j.ajo.2015.10.008.
[50]
Jia Y, Morrison JC, Tokayer J, et al. Quantitative OCT angiography of optic nerve head blood flow. Biomed Opt Express, 2012,3(12): 3127-3137. DOI: 10.1364/BOE.3.003127.
[51]
Jia Y, Wei E, Wang X, et al. Optical coherence tomography angiography of optic disc perfusion in glaucoma. Ophthalmology, 2014,121(7): 1322-1332. DOI: 10.1016/j.ophtha.2014.01.021.
[52]
Wang X, Jiang C, Ko T, et al. Correlation between optic disc perfusion and glaucomatous severity in patients with open-angle glaucoma: an optical coherence tomography angiography study.Graefes Arch Clin Exp Ophthalmol, 2015, 253(9): 1557-1564.DOI: 10.1007/s00417-015-3095-y.
[53]
Liu L, Jia Y, Takusagawa HL, et al. Optical coherence tomography angiography of the peripapillary retina in glaucoma.JAMA Ophthalmol, 2015, 133(9): 1045-1052. DOI: 10.1001/jamaophthalmol.2015.2225.